Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chemotherapy in invasive thymomas: five case reports.

P J Donovan, J F Foley

    Journal of Surgical Oncology
    |September 1, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    F344/NTac Rats Chronically Exposed to Bromodichloroacetic Acid Develop Mammary Adenocarcinomas With Mixed Luminal/Basal Phenotype and Tgfβ Dysregulation.

    Veterinary pathology·2015
    Same author

    Body weight-based natalizumab treatment in adult patients with multiple sclerosis.

    Journal of neurology·2015
    Same author

    NAG-1/GDF-15 prevents obesity by increasing thermogenesis, lipolysis and oxidative metabolism.

    International journal of obesity (2005)·2014
    Same author

    Pathology methods for the evaluation of embryonic and perinatal developmental defects and lethality in genetically engineered mice.

    Veterinary pathology·2011
    Same author

    Clinical outcomes of natalizumab-associated progressive multifocal leukoencephalopathy.

    Neurology·2011
    Same author

    White matter hyperintensities and neuropsychological outcome following carbon monoxide poisoning.

    Neurology·2002

    Chemotherapy regimens, including DTIC, adriamycin, cytoxan, and vincristine, showed objective response and disease stabilization in invasive thymomas and thymic carcinoid tumors. These findings suggest potential efficacy for combination chemotherapy in treating rare thymic malignancies.

    Area of Science:

    • Oncology
    • Thoracic Surgery

    Background:

    • Thymomas and thymic carcinoid tumors are rare malignancies of the thymus.
    • Treatment options for invasive thymomas are limited, necessitating exploration of novel therapeutic strategies.

    Observation:

    • Five cases of invasive thymomas were treated with single-agent or combination chemotherapy.
    • One case of thymic carcinoid demonstrated a 13-month objective response to a combination of DTIC, adriamycin, cytoxan, and vincristine.

    Findings:

    • A second thymic carcinoid case achieved disease stabilization for 9 months with adriamycin, cyclophosphamide, and DTIC, followed by 10 months with fluorouracil and methotrexate.
    • One thymoma case showed disease stabilization for 14 months with oral cytoxan and prednisone.

    Implications:

    Related Experiment Videos

    • Combination chemotherapy regimens may offer therapeutic benefits for patients with invasive thymomas and thymic carcinoid tumors.
    • Further research is warranted to establish optimal chemotherapy protocols for these rare thoracic malignancies.